Guobang Pharma Ltd. (605507.SS) SHH
15.89
+0.17(+1.08%)
Currency In CNY
- General
- Statistics
- Historical Data
- Profile
- Financials
15.89
+0.17(+1.08%)
Currency In CNY
| Market Cap | 9.82B |
| Enterprise Value | 10.02B |
| P/E Ratio | 11.48 |
| PEG Ratio | -4.11 |
| Price/Sales Ratio | 2.04 |
| Price/Book Ratio | 1.01 |
| Enterprise/Revenue | 2.11 |
| Enterprise/EBITDA | 11.22 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
| Profit Margin | 0.13 |
| Operating Margin | 0.14 |
| Return On Assets | 0.07 |
| Return On Equity | 0.09 |
| Revenue | 5.99B |
| Revenue/Share | 11 |
| Gross Profit | 1.46B |
| EBITDA | 1.39B |
| Net Income | 820.82M |
| Diluted EPS | 1.48 |
| Total Cash | 2.77B |
| Total Cash/Share | 4.99 |
| Total Debt | 1.92B |
| Total Debt/Equity | 0.22 |
| Current Ratio | 2.54 |
| Book Value Per Share | 15.74 |
| 52-Week Change | 8.39 |
| 52-Week High | 21.41 |
| 52-Week Low | 13.96 |
| Moving Average 50 Days | 17.11 |
| Moving Average 200 Days | 17.48 |
| Average Volume | 5.45M |
| Shares Outstanding | 782.35M |
| % Held by Institutions | N/A |
| Trailing Annual Dividend Rate | 0.6 |
| Trailing Annual Dividend Yield | 3.78 |
| Payout Ratio | 0.45 |
| Last Split Factor | 7:5 |
| Last Split Date | May 29, 2026 |